These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33821578)

  • 1. Increased bleeding risk with phosphodiesterase-5 inhibitors after left ventricular assist device implantation.
    Jakstaite AM; Luedike P; Schmack B; Pizanis N; Riebisch M; Weymann A; Kamler M; Ruhparwar A; Rassaf T; Papathanasiou M
    ESC Heart Fail; 2021 Aug; 8(4):2419-2427. PubMed ID: 33821578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preimplant Phosphodiesterase-5 Inhibitor Use Is Associated With Higher Rates of Severe Early Right Heart Failure After Left Ventricular Assist Device Implantation.
    Gulati G; Grandin EW; Kennedy K; Cabezas F; DeNofrio DD; Kociol R; Rame JE; Pagani FD; Kirklin JK; Kormos RL; Teuteberg J; Kiernan M
    Circ Heart Fail; 2019 Jun; 12(6):e005537. PubMed ID: 31181953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase-5 inhibitors for left ventricular assist device implantation complicated by right ventricular failure.
    Papathanasiou M; Jakstaite AM; Mincu R; Wernhart S; Ruhparwar A; Rassaf T; Luedike P
    ESC Heart Fail; 2023 Aug; 10(4):2728-2733. PubMed ID: 37056058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase-5 Inhibitors and Outcomes During Left Ventricular Assist Device Support: A Systematic Review and Meta-Analysis.
    Kittipibul V; Blumer V; Angsubhakorn N; Hernandez GA; Chaparro S; Tedford RJ; Agarwal R
    J Card Fail; 2021 Apr; 27(4):477-485. PubMed ID: 33385522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes With Phosphodiesterase-5 Inhibitor Use After Left Ventricular Assist Device: An STS-INTERMACS Analysis.
    Grandin EW; Gulati G; Nunez JI; Kennedy K; Rame JE; Atluri P; Pagani FD; Kirklin JK; Kormos RL; Teuteberg J; Kiernan MS
    Circ Heart Fail; 2022 Apr; 15(4):e008613. PubMed ID: 35332780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic antidepressants and hospitalization for bleeding in patients supported with a continuous flow left ventricular assist device.
    Behrend K; Lillyblad M; Skelton P; Stanberry L; Garberich RF; Eckman PM; Hryniewicz K
    J Heart Lung Transplant; 2021 Dec; 40(12):1599-1604. PubMed ID: 34419371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, predictors, and clinical impact of electrical storm in patients with left ventricular assist devices: New insights from the ASSIST-ICD study.
    Martins RP; Leclercq C; Bourenane H; Auffret V; Boulé S; Loobuyck V; Dambrin C; Mondoly P; Sacher F; Bordachar P; Kindo M; Cardi T; Gaudard P; Rouvière P; Michel M; Gourraud JB; Defaye P; Chavanon O; Kerneis C; Ghodhbane W; Pelcé E; Gariboldi V; Pozzi M; Grinberg D; Litzler PY; Anselme F; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Lellouche N; Pierre B; Bourguignon T; Eschallier R; D'Ostrevy N; Bories MC; Jouan J; Vanhuyse F; Sadoul N; Flécher E; Galand V
    Heart Rhythm; 2019 Oct; 16(10):1506-1512. PubMed ID: 31255846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing in-hospital cardiovascular, thrombotic and bleeding outcomes in patients with chronic liver disease undergoing left ventricular assist device implantation.
    Grant JK; Ebner B; Vincent L; Maning J; Olorunfemi O; Olarte NI; Colombo R; Munagala M; Chaparro S
    Thromb Res; 2021 Jun; 202():184-190. PubMed ID: 33892219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postimplant Phosphodiesterase Type 5 Inhibitors Use Is Associated With Lower Rates of Thrombotic Events After Left Ventricular Assist Device Implantation.
    Xanthopoulos A; Tryposkiadis K; Triposkiadis F; Fukamachi K; Soltesz EG; Young JB; Wolski K; Blackstone EH; Starling RC
    J Am Heart Assoc; 2020 Jul; 9(14):e015897. PubMed ID: 32648508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between novel clinical factors and gastrointestinal bleeding among patients supported with continuous-flow left ventricular assist device therapy.
    Thohan V; Shi Y; Rappelt M; Yousefzai R; Sulemanjee NZ; Hastings TE; Cheema OM; Downey F; Crouch JD
    J Card Surg; 2019 Jun; 34(6):453-462. PubMed ID: 31058372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of right heart failure after left ventricular assist device implantation by phosphodiesterase 5 inhibitor.
    Hamdan R; Mansour H; Nassar P; Saab M
    Artif Organs; 2014 Nov; 38(11):963-7. PubMed ID: 24689700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
    Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of Gastrointestinal Bleeding After Implantation of Left Ventricular Assist Devices Associates With Anatomic Location, Presentation, and Management.
    Tabibian JH; Rhoades DP; Forde KA; McLean RC; Chandrasekhara V
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):448-454. PubMed ID: 29906524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of QRS Duration and Ventricular Pacing on Clinical and Arrhythmic Outcomes in Continuous Flow Left Ventricular Assist Device Recipients: A Multicenter Study.
    Gopinathannair R; Roukoz H; Trivedi JR; Cowger J; Bhan A; Ravichandran A; Bhat G; Birks EJ; Slaughter MS; Ahmed MM
    J Card Fail; 2019 May; 25(5):355-363. PubMed ID: 30797964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged mechanical ventilation after left ventricular assist device implantation: risk factors and clinical implications.
    Papathanasiou M; Mincu RI; Lortz J; Horacek M; Koch A; Pizanis N; Kamler M; Rassaf T; Luedike P
    ESC Heart Fail; 2019 Jun; 6(3):545-551. PubMed ID: 30861636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Age on Outcomes After Destination-Therapy Left Ventricular Assist Device Implantation: An Analysis of the IMACS Registry.
    Aleksova N; Alba AC; Fan CS; Amin F; Kiamanesh O; McGuinty C; Lee H; Duero Posada JG; Ross HJ; Billia F; Rao V
    Can J Cardiol; 2021 Mar; 37(3):467-475. PubMed ID: 32585330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.